Article
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
3 Dec 2022
Abstract excerpt
Cell-free DNA (cfDNA) has the potential to inform tumor subtype classification and help guide clinical precision oncology. Here we develop Griffin, a framework for profiling nucleosome protection and accessibility from cfDNA to study the phenotype of tumors using as low as 0.1x coverage whole genome sequencing data. Griffin employs a GC correction procedure tailored to variable cfDNA fragment sizes, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
